Facteur d'impact:
1.352
Facteur d'impact sur 5 ans:
3.347
SJR:
0.657
SNIP:
0.55
CiteScore™:
2.19
ISSN Imprimer: 1040-8401
Volumes:
|
Critical Reviews™ in Immunology
DOI: 10.1615/CritRevImmunol.v35.i5.30
pages 379-400 Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks
Shawn P. Fahl
Blood Cell Development and Function Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111
Minshi Wang
Blood Cell Development and Function Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111
Yong Zhang
Blood Cell Development and Function Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111
Anne-Cecile E. Duc
Blood Cell Development and Function Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111
David L. Wiest
Blood Cell Development and Function Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 RÉSUMÉRibosomal proteins have long been known to serve critical roles in facilitating the biogenesis of the ribosome and its ability to synthesize proteins. However, evidence is emerging that suggests ribosomal proteins are also capable of performing tissue-restricted, regulatory functions that impact normal development and pathological conditions, including cancer. The challenge in studying such regulatory functions is that elimination of many ribosomal proteins also disrupts ribosome biogenesis and/or function. Thus, it is difficult to determine whether developmental abnormalities resulting from ablation of a ribosomal protein result from loss of core ribosome functions or from loss of the regulatory function of the ribosomal protein. Rpl22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22 is dispensable for both ribosome biogenesis and protein synthesis yet its ablation causes tissue-restricted disruptions in development. Here we review evidence supporting the regulatory functions of Rpl22 and other ribosomal proteins Articles with similar content:
The Contribution of DNA Base Damage to Human Cancer Is Modulated by the Base Excision Repair Interaction Network
Critical Reviews™ in Oncogenesis, Vol.14, 2008, issue 4 Katarzyna D. Arczewska, Hilde Nilsen, Katerina Michalickova, Ian M. Donaldson
Extracellular Vesicles as Potential Mediators of Epigenetic Reprogramming
Forum on Immunopathological Diseases and Therapeutics, Vol.6, 2015, issue 3-4 Anna Lewandowska Ronnegren
Yin Yang I as an Epimodulator of miRNAs in the Metastatic Cascade
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 1-2 Roberta Miceli, Amelia Cimmino, Gianluca Colella, Filomena de Nigris, Mariano Giuseppe Di Salvatore, Flavio Fazioli, Michele Gallo, Carlo Ruosi
Regulation of Lymphoid Cell Apoptosis by Jaks and Stats
Critical Reviews™ in Immunology, Vol.24, 2004, issue 2 Zsuzsanna S. Nagy, Jeremy Ross, Robert A. Kirken, Stanislaw M. Stepkowski, Hanyin Cheng
Histone Deacetylases and Mechanisms of Regulation of Gene Expression
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 1-2 Hong Ping Chen, Ting C. Zhao, Yu Tina Zhao |
Portail numérique | Bibliothèque numérique | eBooks | Revues | Références et comptes rendus | Collections |